Welcome to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
NB: We use cookies to help personalise your web experience and comply with Irish healthcare law. Whatever your choice, you are agreeing to our use of cookies. Please close this browser tab if you don't want to proceed.
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

November 25, 2015

Link with obesity probed

“It is known that men who have prostate cancer are more likely to die of their disease if they are overweight or obese than if they are of a healthy weight,” according to Dr Stephen Finn, Associate Professor in Histopathology and Morbid Anatomy in Trinity College Dublin and Consultant Pathologist at St James’s Hospital.

AIs and bisphosphonates can help improve breast cancer survival

Two new studies, both published in The Lancet, suggest that two different classes of drugs, aromatase inhibitors (AIs) and bisphosphonates, can each improve survival prospects for postmenopausal women with early breast cancer.

Irish standardised tobacco packs less attractive than EU versions

New Irish research published in BMJ Open has found that young people aged 16-17 years old believe standardised packs to be less attractive and their cigarettes to be more harmful than packs with EU Tobacco Products Directive (TPD) labels, which includes picture and text warning covering 65 per cent of the packages.

Image-guided biopsies tested against ultrasound approach

In the largest prospective study to date of image-guided technology for identifying suspicious regions of the prostate to biopsy, researchers compared the ability of this technology to detect high-risk prostate cancer with that of the current standard of unguided prostate biopsy.

Biomarkers ‘can select patients’

In the years to come, personalised medicine will be the goal, Gary Culliton reports in his latest Clinical Update. It is a promising area: now much effort is devoted to studying combinations of different therapies.

New approach to early treatments

Colorectal cancer is a treatable disease and there are a number of effective options available. Progress has been made in diagnosing the disease earlier. Data on which treatment works best in the early stages of the cancer is now being sought.

‘Precision medicine’ is now key

Bowel cancer survival has more than doubled in the last 40 years. But much work remains. Key partners have come together to develop new ways to tailor treatment to the patients who will benefit the most, and to make a difference to their chances of beating this common disease.

A better understanding of resistance sought

Clearly, not every prostate cancer patient will benefit from novel endocrine treatments, Gary Culliton reports in his latest Clinical Update. Thus, personalised medicine is key. The challenge now is to identify which patients will benefit from the drugs and which will not.

TCD study notes savings from early palliative care

Researchers at Trinity College Dublin and Mount Sinai in New York have published new research, which for the first time provides strong evidence on the economic benefits of early palliative care intervention for people with an advanced cancer diagnosis.

Fitness linked to lower risk of some cancers

Men with a high fitness level in mid-life appear to be at lower risk for lung and colorectal cancer, but not prostate cancer, and that higher fitness level also may put them at lower risk of death if they are diagnosed with cancer when they’re older, according to a study published online by JAMA Oncology.

« Previous Page
Next Page »